AI Article Synopsis

  • Canine and murine models of narcolepsy show mutations linked to hypocretin genes, while human narcolepsy with cataplexy correlates with specific immune system markers (DQB1*0602) and low hypocretin levels, hinting at autoimmune factors.
  • A study analyzed serum and cerebrospinal fluid (CSF) samples from narcoleptic and control subjects to identify IgG reactions to preprohypocretin and its cleavage products using several testing methods.
  • Results found no significant IgG reactions to preprohypocretin in narcoleptic subjects, contradicting the original hypothesis that these individuals would show such immune responses.

Article Abstract

Background: Canine models for narcolepsy have mutations of the hypocretin receptor 2 gene, and preprohypocretin knockout murine lines exhibit narcoleptic-like behaviors. Human narcolepsy with cataplexy is associated with human leukocyte antigen DQB1*0602 and reduced hypocretin levels in cerebrospinal fluid, suggesting an autoimmune diathesis. We tested the hypothesis that DQB1*0602-positive narcoleptic subjects with cataplexy have immunoglobulin (Ig)G reactive to human preprohypocretin and its cleavage products.

Methods: Serum samples of 41 DQB1*0602-positive narcoleptic subjects with cataplexy and 55 control subjects were studied, as were 19 narcoleptic and 13 control samples of cerebrospinal fluid. We tested for IgG reactive to preprohypocretin and its major cleavage products (including hypocretin 1 and 2), using immunoprecipitation assays (IP), immunofluorescence microscopy (IF) of Chinese hamster ovarian cells expressing preprohypocretin, and Western blots.

Results: There was no evidence for IgG reactive to preprohypocretin or its cleavage products in CSF of subjects with narcolepsy as measured by IPs, Western blots, and IF. Although the IP with CSF and the C-terminal peptide showed significant differences by two methods of comparison, the control subjects had higher counts per minute than narcoleptic subjects, which was opposite to our hypothesis.

Conclusions: The hypothesis that DQB1*0602-positive narcoleptic subjects with cataplexy have IgG reactive to preprohypocretin or its cleavage products was not supported.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2005.04.026DOI Listing

Publication Analysis

Top Keywords

narcoleptic subjects
20
dqb1*0602-positive narcoleptic
16
subjects cataplexy
16
igg reactive
16
preprohypocretin cleavage
12
reactive preprohypocretin
12
cleavage products
12
human leukocyte
8
leukocyte antigen
8
subjects
8

Similar Publications

Central Disorders of Hypersomnolence: Association with Fatigue, Depression and Sleep Inertia Prevailing in Women.

Brain Sci

November 2022

Department of Neurology, Center of Clinical Neurosciences, General University Hospital, Charles University, Katerinska 30, 128 00 Prague, Czech Republic.

Fatigue, depression, and sleep inertia are frequently underdiagnosed manifestations in narcolepsy and idiopathic hypersomnia. Our cross-sectional study design included diagnostic interview accompanied by assessment instruments and aimed to explore how these factors influence disease severity as well as to elucidate any sex predisposition. One hundred and forty-eight subjects (female 63%) were divided into narcolepsy type 1 (NT1; n = 87, female = 61%), narcolepsy type 2 (NT2; n = 22, female = 59%), and idiopathic hypersomnia (IH; n = 39, female = 69%).

View Article and Find Full Text PDF

Non-sleep symptoms, as depression, anxiety and overweight, are often encountered in narcoleptic patients. The purposes of this study are to evaluate mood, impulsiveness, emotion, alexithymia, and eating behavior in patients with narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) compared to healthy controls and to investigate possible correlations between clinical-demographic data, polysomnographic parameters, and subjective questionnaires. Consecutive patients affected by NT1 and NT2 underwent to Patient Health Questionnaire-9, Generalized Anxiety Disorder-7 Scale, Barratt Impulsivity Scale-11, Difficulties in Emotion Regulation Scale, Toronto Alexithymia Scale, and Eating Disorder Evaluation Questionnaire.

View Article and Find Full Text PDF

Towards an automatic narcolepsy detection on ambiguous sleep staging and sleep transition dynamics joint model.

J Neural Eng

September 2022

Center for Intelligent Medical Electronics (CIME), School of Information Science and Engineering, Fudan University, Shanghai, People's Republic of China.

. Mixing/dissociation of sleep stages in narcolepsy adds to the difficulty in automatic sleep staging. Moreover, automatic analytical studies for narcolepsy and multiple sleep latency test (MSLT) have only done automatic sleep staging without leveraging the sleep stage profile for further patient identification.

View Article and Find Full Text PDF

The national lockdown imposed in several countries to counteract the coronavirus disease 2019 (COVID-19) pandemic led to an unprecedented situation with serious effects on mental health of the general population and of subjects affected by heterogeneous diseases. Considering the positive association between narcoleptic symptoms and creativity, we aimed at exploring the psychological distress associated with COVID-19 restrictions and its relationship with depressive symptoms and creativity in patients with narcolepsy type 1 (NT1). A total of 52 patients with NT1 and 50 healthy controls, who completed a previous study on creativity, were contacted during the first lockdown period to complete an online survey evaluating psychological distress related to the COVID-19 outbreak, sleep quality, narcolepsy and depressive symptoms, and creative abilities.

View Article and Find Full Text PDF

Some studies highlighted that patients with narcolepsy type-1 (NT1) experience high lucid dream frequency, and this phenomenon has been associated with a creative personality. Starting from the well-known "pandemic effect" on sleep and dreaming, we presented a picture of dream activity in pharmacologically treated NT1 patients during the Italian lockdown. Forty-three NT1 patients completed a web-survey during Spring 2021 and were compared with 86 matched-controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!